Medical News Today -
10 Oct 2013 11:00
Adaptive Biotechnologies Corporation, a leading provider of next-generation oncology diagnostics, has announced results from an ovarian cancer study, conducted in collaboration with Fred Hutchinson Cancer Research Center, highlighting the even distribution of immune fighter cells (T-cells) within the tumor...
Share this Article